279 related articles for article (PubMed ID: 19283241)
21. Change in knowledge of women about cervix cancer, human papilloma virus (HPV) and HPV vaccination due to introduction of HPV vaccines.
Donders GG; Bellen G; Declerq A; Berger J; Van Den Bosch T; Riphagen I; Verjans M
Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):93-5. PubMed ID: 19409688
[TBL] [Abstract][Full Text] [Related]
22. HPV vaccination - a paradigm shift in public health.
May J
Aust Fam Physician; 2007 Mar; 36(3):106-11. PubMed ID: 17339969
[TBL] [Abstract][Full Text] [Related]
23. Parental acceptance of Human Papillomavirus vaccines.
Lenselink CH; Gerrits MM; Melchers WJ; Massuger LF; van Hamont D; Bekkers RL
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):103-7. PubMed ID: 17368910
[TBL] [Abstract][Full Text] [Related]
24. Stage of adoption of the human papillomavirus vaccine among college women.
Allen JD; Mohllajee AP; Shelton RC; Othus MK; Fontenot HB; Hanna R
Prev Med; 2009 May; 48(5):420-5. PubMed ID: 19133288
[TBL] [Abstract][Full Text] [Related]
25. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women.
Kahn JA; Rosenthal SL; Jin Y; Huang B; Namakydoust A; Zimet GD
Obstet Gynecol; 2008 May; 111(5):1103-10. PubMed ID: 18448742
[TBL] [Abstract][Full Text] [Related]
26. Improving adolescent health: focus on HPV vaccine acceptance.
Zimet GD
J Adolesc Health; 2005 Dec; 37(6 Suppl):S17-23. PubMed ID: 16310137
[TBL] [Abstract][Full Text] [Related]
27. Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine.
Dinh TA; Rosenthal SL; Doan ED; Trang T; Pham VH; Tran BD; Tran VD; Phan GA; Chu HK; Breitkopf CR
J Adolesc Health; 2007 Jun; 40(6):559-63. PubMed ID: 17531763
[TBL] [Abstract][Full Text] [Related]
28. Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study.
Canfell K; Egger S; Velentzis LS; Brown JD; O'Connell DL; Banks E; Sitas F
Vaccine; 2015 May; 33(20):2387-94. PubMed ID: 25843203
[TBL] [Abstract][Full Text] [Related]
29. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register.
Brotherton J; Gertig D; Chappell G; Rowlands L; Saville M
Commun Dis Intell Q Rep; 2011 Jun; 35(2):197-201. PubMed ID: 22010515
[TBL] [Abstract][Full Text] [Related]
30. Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials.
Paavonen J;
Curr Med Res Opin; 2008 Jun; 24(6):1623-34. PubMed ID: 18435868
[TBL] [Abstract][Full Text] [Related]
31. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.
Wong LP
J Low Genit Tract Dis; 2009 Apr; 13(2):85-93. PubMed ID: 19387128
[TBL] [Abstract][Full Text] [Related]
32. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
[TBL] [Abstract][Full Text] [Related]
33. [Knowledge of human papilloma virus-associated disease among women in general practice].
Petersen LK; Nielsen J; Vaesel H; Brønsgaard PH; Kolby P; Madsen KG
Ugeskr Laeger; 2009 Mar; 171(14):1173-7. PubMed ID: 19338735
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing.
Lutringer-Magnin D; Kalecinski J; Barone G; Leocmach Y; Regnier V; Jacquard AC; Soubeyrand B; Vanhems P; Chauvin F; Lasset C
Vaccine; 2011 Jul; 29(32):5322-8. PubMed ID: 21616114
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
36. The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey.
Tan J; Farrell L; Allen DG
Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):472-7. PubMed ID: 21039383
[TBL] [Abstract][Full Text] [Related]
37. Assessment of knowledge and attitudes of young uninsured women toward human papillomavirus vaccination and clinical trials.
Moreira ED; de Oliveira BG; Neves RC; Costa S; Karic G; Filho JO
J Pediatr Adolesc Gynecol; 2006 Apr; 19(2):81-7. PubMed ID: 16624694
[TBL] [Abstract][Full Text] [Related]
38. Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women.
Barr E; Gause CK; Bautista OM; Railkar RA; Lupinacci LC; Insinga RP; Sings HL; Haupt RM
Am J Obstet Gynecol; 2008 Mar; 198(3):261.e1-11. PubMed ID: 18313445
[TBL] [Abstract][Full Text] [Related]
39. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey.
Caskey R; Lindau ST; Alexander GC
J Adolesc Health; 2009 Nov; 45(5):453-62. PubMed ID: 19837351
[TBL] [Abstract][Full Text] [Related]
40. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
Harper DM
Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
